3
Announcements
Trials
Browse
Landscape
Status
Terminated
1
No longer available
1
Sponsor Class
INDUSTRY
1
Study Type
Expanded_access
1
Sponsor
Cancer Type
Dermatologic
1
CNS
1
Conditions
Melanoma
1
Glioma
1
Glioblastoma
1
Interventions
trametinib
3
dabrafenib
3
talimogene laherparepvec
2
pembrolizumab
2
Nivolumab
2
Ipilimumab
2
pegilodecakin
1
omaveloxolone
1
efineptakin alfa
1
aldesleukin
1
Melphalan
1
Cyclophosphamide
1
AM0010
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
No longer available
×
Melanoma
×
efineptakin alfa
×
Clear all
NCT04289155
2022-03-17
Individual Patient Compassionate Use of GX-I7
Genexine, Inc.
No longer available